- cafead   Oct 17, 2022 at 11:32: PM
via After two legal defeats, Pfizer is taking its copay assistance lawsuit for costly rare heart disease drug tafamidis to the Supreme Court. Once again, the company is challenging the U.S. Department of Health and Human Services’ (HHS') interpretation of anti-kickback law.
article source
article source